One simple approach is to use internal known positive controls, such as p53 immunohistochemistry in ovarian serous carcinoma [31] with a known negative control (in our case, a benign lymph node), and train within each case an algorithm based on pixel intensity and texture features. This evidence concerns the gene TP53 and ovarian serous carcinoma.